Hana Pharm Co Ltd Ordinary Shares 293480
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 13,160.00
- Day Range
- KRW 13,160.00–13,280.00
- 52-Week Range
- KRW 13,090.00–15,100.00
- Bid/Ask
- KRW 13,160.00 / KRW 13,250.00
- Market Cap
- KRW 229.22 Bil
- Volume/Avg
- 21,220 / 17,902
Key Statistics
- Price/Earnings (Normalized)
- 10.21
- Price/Sales
- 1.02
- Dividend Yield (Trailing)
- 3.85%
- Dividend Yield (Forward)
- 3.85%
- Total Yield
- 3.85%
Company Profile
Hana Pharm Co Ltd is a Korea based company engaged in drug development. It offers products for anesthetics, narcotic analgesics, antiemetics, antibiotics, dermatology, urinology, osteoporosis, and central nervous system.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 707
- Website
- http://www.hanaph.co.kr
Comparables
Valuation
|
Metric
|
293480
|
140410
|
016580
|
|---|---|---|---|
Price/Earnings (Normalized) | 10.21 | — | 7.40 |
Price/Book Value | 0.82 | 20.81 | 0.62 |
Price/Sales | 1.02 | 32.25 | 0.96 |
Price/Cash Flow | 7.54 | — | 5.65 |
Price/Earnings
293480
140410
016580
Financial Strength
|
Metric
|
293480
|
140410
|
016580
|
|---|---|---|---|
Quick Ratio | 0.93 | 2.17 | 3.93 |
Current Ratio | 1.82 | 2.51 | 5.30 |
Interest Coverage | — | −43.24 | 1,345.19 |
Quick Ratio
293480
140410
016580
Profitability
|
Metric
|
293480
|
140410
|
016580
|
|---|---|---|---|
Return on Assets (Normalized) | 6.72% | −17.65% | 7.92% |
Return on Equity (Normalized) | 8.59% | −33.91% | 8.87% |
Return on Invested Capital (Normalized) | 7.47% | −28.13% | 7.89% |
Return on Assets
293480
140410
016580
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Hwwwslbksr | Ntbmj | $77.1 Bil | |
MKKGY
| Merck KGaA ADR | Zkxyynjlc | Wxpnh | $74.3 Bil | |
HLN
| Haleon PLC ADR | Sfqgbbtn | Zzmx | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Xfcbvnqc | Rkgbb | $18.3 Bil | |
VTRS
| Viatris Inc | Zdsmycbs | Jdjhr | $13.5 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Fmxbhfwh | Jfg | $11.7 Bil | |
CTLT
| Catalent Inc | Hfqvgxtp | Srrvtg | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Zlnxnyft | Vpz | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Fqqktstby | Hftpp | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Yxvxyssyw | Wksplv | $3.5 Bil |